Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Leary

Showing results (41-50 of 217) with videos related to

Pageof 22
Sort By:
Gynecologic Oncology|August 24, 2020
A new score based on biomarker values to predict the prognosis of locally advanced cervical cancerAmandine Maulard, Cyrus Chargari, Matthieu Faron, et al.
Annals of Surgical Oncology|November 3, 2020
Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian TumorsSebastien Gouy, Sophie Maria, Matthieu Faron, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitorsLola Paulet, Alexis Trecourt, Alexandra Leary, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie, et al.
Annals of Surgical Oncology|October 1, 2021
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and ManagementGiulio Ricotta, Amandine Maulard, Massimo Candiani, et al.
Journal of Clinical Medicine|November 13, 2021
Cervical Cancer and Fertility-Sparing TreatmentFrançois Zaccarini, Claire Sanson, Amandine Maulard, et al.
Endocrine-Related Cancer|October 1, 2008
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2Sunil Pancholi, Anne E Lykkesfeldt, Caroline Hilmi, et al.
Bulletin Du Cancer|August 6, 2014
[Targeted therapy in locally and metastatic recurrent cervical cancers]Romain Geiss, Thibault De La Motte Rouge, Coraline Dubot, et al.
Journal of Gynecologic Oncology|July 24, 2025
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancerFelix Blanc-Durand, Etienne Rouleau, Patricia Pautier, et al.
Bulletin Du Cancer|December 15, 2012
[The molecular biology of epithelial ovarian cancer]Alexandra Leary, Patricia Pautier, Youssef Tazi, et al.
Pageof 22

Showing results (41-50 of 217) with videos related to

Sort By:
Pageof 22
Gynecologic Oncology|August 24, 2020
A new score based on biomarker values to predict the prognosis of locally advanced cervical cancerAmandine Maulard, Cyrus Chargari, Matthieu Faron, et al.
Annals of Surgical Oncology|November 3, 2020
Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian TumorsSebastien Gouy, Sophie Maria, Matthieu Faron, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitorsLola Paulet, Alexis Trecourt, Alexandra Leary, et al.
Therapeutic Advances in Medical Oncology|March 16, 2026
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancerJuan Francisco Grau Béjar, Elisa Yaniz Galende, Catherine Genestie, et al.
Annals of Surgical Oncology|October 1, 2021
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and ManagementGiulio Ricotta, Amandine Maulard, Massimo Candiani, et al.
Journal of Clinical Medicine|November 13, 2021
Cervical Cancer and Fertility-Sparing TreatmentFrançois Zaccarini, Claire Sanson, Amandine Maulard, et al.
Endocrine-Related Cancer|October 1, 2008
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2Sunil Pancholi, Anne E Lykkesfeldt, Caroline Hilmi, et al.
Bulletin Du Cancer|August 6, 2014
[Targeted therapy in locally and metastatic recurrent cervical cancers]Romain Geiss, Thibault De La Motte Rouge, Coraline Dubot, et al.
Journal of Gynecologic Oncology|July 24, 2025
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancerFelix Blanc-Durand, Etienne Rouleau, Patricia Pautier, et al.
Bulletin Du Cancer|December 15, 2012
[The molecular biology of epithelial ovarian cancer]Alexandra Leary, Patricia Pautier, Youssef Tazi, et al.
Pageof 22